Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma

Detalles Bibliográficos
Autores principales: Liu, Hailiang, Xu, Yong, Liang, Kai, Liu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728366/
https://www.ncbi.nlm.nih.gov/pubmed/35004334
http://dx.doi.org/10.3389/fonc.2021.817747
_version_ 1784626718882922496
author Liu, Hailiang
Xu, Yong
Liang, Kai
Liu, Rong
author_facet Liu, Hailiang
Xu, Yong
Liang, Kai
Liu, Rong
author_sort Liu, Hailiang
collection PubMed
description
format Online
Article
Text
id pubmed-8728366
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87283662022-01-06 Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma Liu, Hailiang Xu, Yong Liang, Kai Liu, Rong Front Oncol Oncology Frontiers Media S.A. 2021-12-22 /pmc/articles/PMC8728366/ /pubmed/35004334 http://dx.doi.org/10.3389/fonc.2021.817747 Text en Copyright © 2021 Liu, Xu, Liang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Hailiang
Xu, Yong
Liang, Kai
Liu, Rong
Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
title Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
title_full Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
title_fullStr Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
title_full_unstemmed Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
title_short Corrigendum: Immune Cells Combined With NLRP3 Inflammasome Inhibitor Exert Better Antitumor Effect on Pancreatic Ductal Adenocarcinoma
title_sort corrigendum: immune cells combined with nlrp3 inflammasome inhibitor exert better antitumor effect on pancreatic ductal adenocarcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728366/
https://www.ncbi.nlm.nih.gov/pubmed/35004334
http://dx.doi.org/10.3389/fonc.2021.817747
work_keys_str_mv AT liuhailiang corrigendumimmunecellscombinedwithnlrp3inflammasomeinhibitorexertbetterantitumoreffectonpancreaticductaladenocarcinoma
AT xuyong corrigendumimmunecellscombinedwithnlrp3inflammasomeinhibitorexertbetterantitumoreffectonpancreaticductaladenocarcinoma
AT liangkai corrigendumimmunecellscombinedwithnlrp3inflammasomeinhibitorexertbetterantitumoreffectonpancreaticductaladenocarcinoma
AT liurong corrigendumimmunecellscombinedwithnlrp3inflammasomeinhibitorexertbetterantitumoreffectonpancreaticductaladenocarcinoma

Ejemplares similares